875895-67-3 Usage
Uses
Used in Food and Beverage Industry:
Benzoic acid, 2-(bromomethyl)-4-hydroxy-, methyl ester is used as a preservative to prevent the growth of bacteria, fungi, and yeast, ensuring the freshness and safety of food and beverages.
Used in Pharmaceutical Industry:
Benzoic acid, 2-(bromomethyl)-4-hydroxy-, methyl ester is used as a precursor in the manufacturing of various pharmaceuticals, contributing to the development of new drugs and treatments.
Used in Fragrance Industry:
Benzoic acid, 2-(bromomethyl)-4-hydroxy-, methyl ester is used as a precursor in the production of fragrances, adding unique scents and enhancing the sensory experience of various products.
Used in Organic Compounds Synthesis:
Benzoic acid, 2-(bromomethyl)-4-hydroxy-, methyl ester is used as a precursor in the synthesis of other organic compounds, enabling the creation of a wide range of chemical products.
It is important to handle Benzoic acid, 2-(bromomethyl)-4-hydroxy-, methyl ester with caution and follow proper safety protocols when working with it, as it can be harmful if ingested or inhaled in large amounts.
Check Digit Verification of cas no
The CAS Registry Mumber 875895-67-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,8,9 and 5 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 875895-67:
(8*8)+(7*7)+(6*5)+(5*8)+(4*9)+(3*5)+(2*6)+(1*7)=253
253 % 10 = 3
So 875895-67-3 is a valid CAS Registry Number.
875895-67-3Relevant academic research and scientific papers
PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF
-
, (2021/06/26)
Provided herein are compounds, compositions, and methods useful for degrading protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer 5 or a metabolic disease.
Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity
Ruchelman, Alexander L.,Man, Hon-Wah,Zhang, Weihong,Chen, Roger,Capone, Lori,Kang, Jian,Parton, Anastasia,Corral, Laura,Schafer, Peter H.,Babusis, Darius,Moghaddam, Mehran F.,Tang, Yang,Shirley, Michael A.,Muller, George W.
, p. 360 - 365 (2013/02/23)
A series of analogs of the immunomodulary drugs lenalidomide (1) and pomalidomide (2), in which the amino group is replaced with various isosteres, was prepared and assayed for immunomodulatory activity and activity against cancer cell lines. The 4-methyl and 4-chloro analogs 4 and 15, respectively, displayed potent inhibition of tumor necrosis factor-α (TNF-α) in LPS-stimulated hPBMC, potent stimulation of IL-2 in a human T cell co-stimulation assay, and anti-proliferative activity against the Namalwa lymphoma cell line. Both of these analogs displayed oral bioavailability in rat.
